Deals of the year 2009: M&A – Pfizer prepares for life after Lipitor
Euromoney Limited, Registered in England & Wales, Company number 15236090
4 Bouverie Street, London, EC4Y 8AX
Copyright © Euromoney Limited 2024
Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Deals of the year 2009: M&A – Pfizer prepares for life after Lipitor

A big M&A deal was a no-brainer, but the Wyeth buyout was still a surprise.

Transaction value: $68.4 billion
Date: Announced January 2009, completed October 2009
Advisers to Pfizer: Bank of America Merrill Lynch, Goldman Sachs, JPMorgan, Barclays Capital, Citi
Advisers to Wyeth: Evercore, Morgan Stanley
Global coordinators: Goldman Sachs, HSBC, JPMorgan

Although secondary financial markets recovered strongly last year and primary debt and equity capital markets bankers were all kept busy, the shattered confidence of corporate management teams and investors was most evident in the collapse of M&A volume. Global volume totalled $2.4 trillion in 2009, the lowest since 2004 and down 24% on the $3.17 trillion announced in 2008, according to Dealogic. Financial sponsor activity fell sharply: buyouts totalled $75.9 billion in 2009, the lowest volume since 2001, down from $191.8 billion in 2008.

Gift this article